Teleflex (NYSE:TFX) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?

Key Points

• Teleflex shares crossed above their 200-day moving average, reaching $132.21 before last trading near $130.48, slightly above the $130.62 average.
• Analyst sentiment is moderately bullish: the stock has a consensus “Moderate Buy” rating and a $154.40 price target, with recent targets raised as high as $170.
• Teleflex exceeded quarterly earnings and revenue estimates, reporting $1.76 in EPS and $570.33 million in revenue, while maintaining a quarterly dividend of $0.34 per share.

Teleflex Incorporated (NYSE:TFX - Get Free Report) crossed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $130.62 and traded as high as $132.21. Teleflex shares last traded at $130.4750, with a volume of 400,446 shares.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Wall Street Zen raised shares of Teleflex from a "sell" rating to a "hold" rating in a research note on Sunday, August 9th. Zacks Research upgraded shares of Teleflex from a "hold" rating to a "strong-buy" rating in a report on Thursday, September 24th. Piper Sandler reissued an "overweight" rating and set a $169.00 price objective (up from $160.00) on shares of Teleflex in a research report on Friday, August 7th. BMO Capital Markets began coverage on shares of Teleflex in a research report on Wednesday, July 8th. They set an "outperform" rating and a $159.00 price objective on the stock. Finally, Needham & Company LLC raised their target price on Teleflex from $159.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, August 25th. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $154.40.

Teleflex Price Performance

The company has a quick ratio of 2.12, a current ratio of 2.60 and a debt-to-equity ratio of 0.94. The business has a 50-day moving average price of $130.95 and a two-hundred day moving average price of $130.62. The company has a market capitalization of $5.53 billion, a price-to-earnings ratio of -5.60, a price-to-earnings-growth ratio of 0.88 and a beta of 0.83.

Teleflex (NYSE:TFX - Get Free Report) last posted its earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. During the same period in the previous year, the firm posted $3.73 earnings per share. The firm's revenue for the quarter was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, research analysts anticipate that Teleflex Incorporated will post 7.22 EPS for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend was Friday, August 14th. Teleflex's payout ratio is currently -5.84%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. GAMMA Investing LLC boosted its position in shares of Teleflex by 9.8% during the third quarter. GAMMA Investing LLC now owns 921 shares of the medical technology company's stock valued at $115,000 after buying an additional 82 shares during the last quarter. Hsbc Holdings PLC grew its holdings in Teleflex by 4.7% during the first quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company's stock worth $222,000 after buying an additional 84 shares in the last quarter. Baldwin Wealth Partners LLC MA raised its position in Teleflex by 7.5% in the 3rd quarter. Baldwin Wealth Partners LLC MA now owns 1,702 shares of the medical technology company's stock valued at $213,000 after buying an additional 119 shares during the last quarter. Leonteq Securities AG raised its position in Teleflex by 13.6% in the 1st quarter. Leonteq Securities AG now owns 1,164 shares of the medical technology company's stock valued at $139,000 after buying an additional 139 shares during the last quarter. Finally, Sage Rhino Capital LLC raised its position in Teleflex by 9.5% in the 1st quarter. Sage Rhino Capital LLC now owns 1,837 shares of the medical technology company's stock valued at $220,000 after buying an additional 159 shares during the last quarter. Institutional investors own 95.62% of the company's stock.

About Teleflex

Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.

The company's portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.